TrianglePUBLICATIONS · 12649108
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2003 Apr
- First author
- van den Bent MJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- van den Bent MJ
- type
- Author
- name
- Chinot O
- type
- Author
- name
- Boogerd W
- type
- Author
- name
- Bravo Marques J
- type
- Author
- name
- Taphoorn MJ
- type
- Author
- name
- Kros JM
- type
- Author
- name
- van der Rijt CC
- type
- Author
- name
- Vecht CJ
- type
- Author
- name
- De Beule N
- type
- Author
- name
- Baron B
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- van den Bent MJ
- type
- Author
- name
- Chinot O
- type
- Author
- name
- Boogerd W
- type
- Author
- name
- Bravo Marques J
- type
- Author
- name
- Taphoorn MJ
- type
- Author
- name
- Kros JM
- type
- Author
- name
- van der Rijt CC
- type
- Author
- name
- Vecht CJ
- type
- Author
- name
- De Beule N
- type
- Author
- name
- Baron B
- type
- Author
- bibliography ids
- nci-bib-9f39b5bc0210db64eed465bb
- book metadata
- content sha256
- efeb7a3a39a7740d6cec301f0403401cb75bb53c2f399373362426418947be68
- document type
- citation
- dois
- 10.1093/annonc/mdg157
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12649108
- immutable id
- pubmed:12649108@efeb7a3a39a7740d6cec301f0403401cb75bb53c2f399373362426418947be68
- journal
- abbreviation
- Ann Oncol
- issn electronic
- Source null
- issn print
- 0923-7534
- issue
- 4
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 599-602
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12649108
- provenance
- batch id
- 6646708a43dc2007bef0
- provider
- NCBI PubMed ESummary
- record sha256
- 7c06d043d04ab1b0a6efb92697b4f45349fd7d3a5c8110e0bf4bfd854298e8d1
- response sha256
- 2e7ae6114dac3dd1eb0d8799c51ad362081554b4e07621e9ff80c0fb43c178c7
- retrieved at
- 2026-09-09T23:45:48.511831+00:00
- publication date
- display
- 2003 Apr
- precision
- month
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
Preserved source evidence · Not medical advice